ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 2094

$1M Total Retail Price of All Prescriptions

Rank: 89 out of 2094

659 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 659 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

2% of this provider’s 659 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 12,021 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 525 420 1 4
AMLODIPINE BESYLATE 426 374 2 2
DIOVAN HCT 389 326 3 28
GLIMEPIRIDE 329 278 4 31
METOPROLOL SUCCINATE 328 282 5 9
FUROSEMIDE 326 283 6 6
SIMVASTATIN 321 265 7 1
METFORMIN HCL 306 251 8 8
ZOLPIDEM TARTRATE 306 252 8 14
CLONIDINE HCL 298 234 10 62
NEXIUM 281 229 11 16
ATORVASTATIN CALCIUM 262 229 12 5
DIOVAN 204 189 13 13
LOSARTAN POTASSIUM 197 159 14 17
CRESTOR 194 130 15 15
TAMSULOSIN HCL 190 173 16 29
LOSARTAN-HYDROCHLOROTHIAZIDE 184 142 17 52
DONEPEZIL HCL 179 167 18 20
PROAIR HFA 174 129 19 45
CLOPIDOGREL 167 141 20 22
TRAMADOL HCL-ACETAMINOPHEN 166 140 21 100
GLYBURIDE-METFORMIN HCL 166 139 R 21 94
ENALAPRIL MALEATE 158 118 23 25
CARVEDILOL 152 137 24 19
LOVAZA 150 114 25 53
METOPROLOL TARTRATE 144 125 26 10
NAPROXEN 144 93 26 84
GABAPENTIN 134 109 28 23
LEVOTHYROXINE SODIUM 130 109 29 3
METOCLOPRAMIDE HCL 128 102 30 141
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 96 31 55
LYRICA 121 121 32 85
NAMENDA 120 120 33 32
WARFARIN SODIUM 118 114 34 11
EXFORGE 117 113 35 105
MELOXICAM 117 92 35 49
ACTOS 116 91 37 112
ALENDRONATE SODIUM 114 99 38 30
MECLIZINE HCL 109 89 39 103
PROCTOZONE-HC 108 99 40 266
CLOTRIMAZOLE-BETAMETHASONE 106 65 41 91
ATENOLOL 106 68 41 21
VOLTAREN 106 94 41 109
LACTULOSE 104 89 44 65
NABUMETONE 101 96 45 203
PLAVIX 100 84 46 38
CELEBREX 96 78 47 74
NIFEDIPINE ER 87 80 48 96
LANTUS SOLOSTAR 86 58 49 76
ADVAIR DISKUS 82 61 50 36
LANTUS 80 60 51 66
AMLODIPINE BESYLATE-BENAZEPRIL 79 67 52 58
TRAMADOL HCL 78 52 53 33
JANUVIA 77 58 54 35
FAMOTIDINE 76 59 55 34
JANUMET 73 57 56 86
LISINOPRIL 73 64 56 7
SINGULAIR 71 53 58 64
AZITHROMYCIN 71 62 58 27
VALSARTAN-HYDROCHLOROTHIAZIDE 70 50 60 225
SYMBICORT 70 61 60 149
HYDRALAZINE HCL 67 52 62 89
DILTIAZEM 24HR CD 65 43 63 110
SUCRALFATE 65 59 63 277
HYDROCHLOROTHIAZIDE 61 56 65 12
MUPIROCIN 59 45 66 117
FLUTICASONE PROPIONATE 57 45 67 41
DIGOXIN 57 55 67 51
NIASPAN 57 50 67 145
RANITIDINE HCL 56 54 70 80
ESCITALOPRAM OXALATE 54 44 71 46
KETOCONAZOLE 53 35 72 196
METFORMIN HCL ER 53 39 72 67
LIPITOR 53 47 72 39
BYSTOLIC 51 39 75 83
ISOSORBIDE MONONITRATE ER 51 40 75 57
BENICAR HCT 50 41 77 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.